William E.: Rho-Kinase Identified as a Novel Target in Post-COVID-19 Vascular Disease
William E. shared a post on LinkedIn about a recent article by Robert A Sykes et al. published in European Heart Journal – Cardiovascular Pharmacotherapy:
“Vascular mechanisms of post-COVID-19 conditions: Rho-kinase is a novel target for therapy.”
Article: Vascular mechanisms of post-COVID-19 conditions: Rho-kinase is a novel target for therapy
Authors: Robert A Sykes, Karla B Neves, Rhéure Alves-Lopes, Ilaria Caputo, Kirsty Fallon, Nigel B Jamieson, Anna Kamdar, Assya Legrini, Holly Leslie, Alasdair McIntosh, Alex McConnachie, Andrew Morrow, Richard W McFarlane, Kenneth Mangion, John McAbney, Augusto C Montezano, Rhian M Touyz, Colin Wood, Colin Berry
Read the Full Article on European Heart Journal – Cardiovascular Pharmacotherapy
Stay updated with Hemostasis Today.
-
Feb 6, 2026, 17:00Merry Mazmanian: Exploring the Development of Biobank Infrastructure in Armenia
-
Feb 6, 2026, 16:58Wolfgang Miesbach: A Hidden Platelet Activation State Bridging Thrombosis and Inflammation
-
Feb 6, 2026, 16:41Lester Leung on Launching a New Era in Preventing Silent Stroke and Dementia
-
Feb 6, 2026, 16:24Roseline d’Oiron on The Challenges of Pregnancy and Childbirth in Glanzmann Thrombasthenia at EAHAD 2026
-
Feb 6, 2026, 16:22Louise St Germain Bannon: ISTH Collaborates With EAHAD to Advance Care for People with Bleeding Disorders
-
Feb 6, 2026, 16:03Paula Loughnane: Honoured to Be Awarded Best SLAM Presentation at EAHAD 2026 AHP Day
-
Feb 6, 2026, 15:58Robert Hamilton: What Actually Makes Technology Stick at The Bedside
-
Feb 6, 2026, 15:43Gevorg Tamamyan: Building a Team That Creates Miracles
-
Feb 6, 2026, 15:20Shekher Bose: Asundexian’s Targeted Factor XIa Inhibition May Transform Secondary Stroke Prevention Strategies